Climb Bio, Inc.
CLYMNasdaqCIK 1768446HealthcareFiscal year ends Dec 31
Reports and events: 113 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2606:24 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-430997 |
| 2026-10-2317:26 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-430681 |
| 2026-09-0307:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-381060 |
| 2026-08-1408:30 ET | 8-K | 8.01 Other events | 0001193125-26-350596 |
| 2026-08-0607:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336774 |
| 2026-08-0607:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336762 |
| 2026-07-0716:41 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000189 |
| 2026-07-0116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-292567 |
| 2026-06-1216:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-269567 |
| 2026-06-1107:12 ET | 8-K | 8.01 Other events | 0001193125-26-266688 |
| 2026-06-0816:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-261716 |
| 2026-06-0507:12 ET | 8-K | 8.01 Other events | 0001193125-26-258372 |
| 2026-05-0707:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210357 |
| 2026-05-0707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210295 |
| 2026-05-0507:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-205079 |
| 2026-04-2918:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000123 |
| 2026-04-2808:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-183711 |
| 2026-04-2416:13 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001193125-26-177271 |
| 2026-04-0316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-142114 |
| 2026-03-0507:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-092546 |
| 2026-03-0507:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092520 |
| 2026-01-0807:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006994 |
| 2025-12-3116:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-338318 |
| 2025-12-1519:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000074 |
| 2025-12-1108:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-315108 |
| 2025-11-0607:21 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268086 |
| 2025-11-0607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268075 |
| 2025-10-1707:11 ET | 8-K | 8.01 Other events | 0001193125-25-241951 |
| 2025-10-1617:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-241629 |
| 2025-10-0716:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-233582 |
| 2025-10-0117:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-227025 |
| 2025-09-2907:48 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-221756 |
| 2025-08-1207:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106916 |
| 2025-08-1207:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106913 |
| 2025-06-1807:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-142359 |
| 2025-06-0516:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-135864 |
| 2025-05-2316:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-125866 |
| 2025-05-1407:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070902 |
| 2025-05-1407:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070901 |
| 2025-04-2516:01 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001193125-25-096697 |
| 2025-04-0107:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-069668 |
| 2025-03-2516:46 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-062629 |
| 2025-03-2516:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-044350 |
| 2025-01-1008:08 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events | 0001193125-25-004129 |
| 2024-11-1216:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-125336 |
| 2024-11-1216:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125294 |
| 2024-10-1507:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-237196 |
| 2024-10-0216:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-231167 |
| 2024-08-2717:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-207854 |
| 2024-08-2607:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-206655 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:52 ET. Listed shows no prices and gives no investment advice.